Literature DB >> 6766092

Acid hydrolases in serum from patients with lysosomal disorders.

B Hultberg, A Isaksson, S Sjöblad, P A Ockerman.   

Abstract

The activity of acid hydrolases was studied in serum from patients with mucolipidosis (II and III) and other lysosomal disorders. In mucolipidosis II and III all hydrolases examined except alpha-glucosidase, beta-glucosidase and acid phosphatase were greatly increased. High values for beta-galactosidase were seen in mucopolysaccharidosis types I and II, Gaucher's disease, juvenile amaurotic idiocy and metachromatic leucodystrophy. N-Acetyl-beta-glucosaminidase activity was high in mucopolysaccharidosis types I, II, III and Gaucher's disease. The activity of beta-glucuronidase was increased in mucopolysaccharidosis types I, II and III, Gaucher's disease, juvenile amaurotic idiocy and metachromatic leucodystrophy. Acid phosphatase had increased activity only in Gaucher's disease. In several lysosomal storage disorders no increased values could be found. It is suggested that high values in serum from patients with lysosomal storage disorders (not including mucolipidosis II and III) may depend upon liver cell damage, which disturbs the clearing of acid hydrolases from serum.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6766092     DOI: 10.1016/0009-8981(80)90182-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

Review 1.  Are there useful biochemical markers of disease activity in lysosomal storage diseases?

Authors:  B Winchester
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

2.  Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome.

Authors:  A J Ungewickell; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention.

Authors:  Sofie M A Walenbergh; Tom Houben; Sander S Rensen; Veerle Bieghs; Tim Hendrikx; Patrick J van Gorp; Yvonne Oligschlaeger; Mike L J Jeurissen; Marion J J Gijbels; Wim A Buurman; Anita C E Vreugdenhil; Jan Willem M Greve; Jogchum Plat; Marten H Hofker; Satish Kalhan; Jussi Pihlajamäki; Patrick Lindsey; Ger H Koek; Ronit Shiri-Sverdlov
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

4.  Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague⁻Dawley Rats .

Authors:  Princy Khurana; Tulasi Yadati; Sandeep Goyal; Atul Dolas; Tom Houben; Yvonne Oligschlaeger; Anil K Agarwal; Aditya Kulkarni; Ronit Shiri-Sverdlov
Journal:  Biomolecules       Date:  2019-05-04

5.  Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice.

Authors:  Tulasi Yadati; Tom Houben; Albert Bitorina; Yvonne Oligschlaeger; Marion J Gijbels; Ronny Mohren; Dieter Lütjohann; Princy Khurana; Sandeep Goyal; Aditya Kulkarni; Jan Theys; Berta Cillero-Pastor; Ronit Shiri-Sverdlov
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.